V-RULES: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Thomas Leblanc, 4161547

REEVALUATING MDRM MUTATIONS IN DE NOVO AML PROGNOSIS WITH A SINGLE-CENTRE REAL-WORLD EXPERIENCE IN CHINA

EHA Library, Ning Liu, 4161548

USE OF HETERODUPLEX ANALYSIS FOR SCREENING 4BP INSERTIONS IN THE NPM1 GENE IN AML PATIENTS

EHA Library, Tatiana Subbotina, 4161549

PATTERNS OF POST-REMISSION THERAPY DE-ESCALATION IN ACUTE MYELOID LEUKEMIA PATIENTS IN REMISSION RECEIVING ONGOING CYCLES OF VENETOCLAX AND HYPOMETHYLATING AGENTS

EHA Library, Jonathan Canaani, 4161550

MECOM-REARRANGED AML SHOWS LOW RESPONSE RATES TO HYPOMETHYLATING AGENTS PLUS VENETOCLAX

EHA Library, Giorgio Gramazio, 4161551

PROGNOSTIC AND THERAPEUTIC IMPLICATIONS OF EARLY ASSESSMENT IN R/R AML AND HIGH-RISK MDS PATIENTS TREATED WITH SELINEXOR IN COMBINATION WITH VENETOCLAX AND AZACITIDINE

EHA Library, Shuai Su, 4161552

OUTCOMES OF ACUTE MYELOID LEUKEMIA: DOES SECONDARY LEUKEMIA MATTER?

EHA Library, Lu Yu, 4161553

CLADRIBINE FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA - A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY.

EHA Library, Maya Zlotnick, 4161554

CLINICAL OUTCOMES OF AML PATIENTS UNDERGOING LESS INTENSIVE TREATMENT WITH VENETOCLAX AND REQUIRING INTENSIVE CARE UNIT ADMISSION IN A COMPREHENSIVE CANCER CENTER

EHA Library, Louison Brac De La Perriere, 4161555

INTEGRATION OF NEXT-GENERATION SEQUENCING IN THE DETECTION OF MEASURABLE RESIDUAL DISEASE AND PROGNOSTIC STRATIFICATION IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC NEOPLASMS, FROM INDUCTION THERAPY TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Elena Crisà, 4161556

THE IMPACT OF MEASURABLE RESIDUAL DISEASE ON OUTCOMES IN PATIENTS WITH FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Onyee Chan, 4161557

CLINICAL EFFICACY ANALYSIS OF DECITABINE COMBINED WITH THE STANDARD INDUCTION REGIMEN IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Yi Wang, 4161558

ASSOCIATION OF VENETOCLAX TO MEC CHEMOTHERAPY IN FIT PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Corrado Zuanelli Brambilla, 4161559

UPDATES FROM A SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA HYPOMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Xiao-Ning Gao, 4161560

HOW TO IMPROVE THE EFFICACY OF VENETOCLAX AND AZACITIDINE(VA)FOR AML WITH A MONOCYTIC PHENOTYPE?

EHA Library, Xiaowen Tang, 4161561

CHART REVIEW STUDY ON THE REAL-WORLD CYTOPENIA MANAGEMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND HYPOMETHYLATING AGENTS

EHA Library, Yuexi Wang, 4161562

MANNITOL AND ARSENIC TRIOXIDE COMBINATION THERAPY IMPROVES PROGNOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS WITH CENTRAL NERVOUS SYSTEM RELAPSE

EHA Library, Yubing Zhao, 4161563

DECEASED DONOR BONE MARROW TRANSPLANT: FIRST EVER HUMAN CASE REPORT OF SUCCESSFUL ENGRAFTMENT AFTER INFUSION OF A CRYOPRESERVED DECEASED DONOR BONE MARROW IN A PATIENT WITH AML

EHA Library, Sagar Munjal, 4161564

GO-FIRST: REAL-WORLD DATA OF FRONT LINE GEMTUZUMAB OZOGAMICIN IN INTERMEDIATE AND FAVORABLE RISK AML PATIENTS IN A MULTICENTER RETROSPECTIVE CHART REVIEW

EHA Library, Wolfgang Sperr, 4161565

A PHASE 2 STUDY OF OLUTASIDENIB IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: OUTCOMES BY NUMBER OF PRIOR TREATMENT REGIMENS

EHA Library, Stéphane De Botton, 4161566

STUDY OF DNA METHYLATION LEVELS IN JMML PATIENTS AND ITS CLINICAL SIGNIFICANCE

EHA Library, chenmeng Liu, 4161567

GENETIC DIVERSITY IN ACUTE MYELOID LEUKEMIA: THEINFL UENCE OF EUROPEAN ANCESTRY ON PROGNOSIS IN AHISPANIC COHORT

EHA Library, Juan Ontiveros-Austria, 4161568

IMPACT-AML: A EUROPEAN RANDOMIZED PRAGMATIC CLINICAL TRIAL OPTIMIZING TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA

EHA Library, Giovanni Martinelli, 4161569

CLADRIBINE, LOW-DOSE CYTARABINE, AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA RELAPSED OR REFRACTORY TO VENETOCLAX

EHA Library, Alexander Li, 4161570

EFFECTIVENESS OF PRIMARY ANTIFUNGAL PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH VENETOCLAX-BASED LOW-INTENSITY THERAPY

EHA Library, Ana Basquiera, 4161571

ON- AND OFF-TRIAL EXPERIENCE SUPPORTS FRACTIONATED GEMTUZUMAB OZOGAMICIN WITH HIDAC-BASED INDUCTION CHEMOTHERAPY IS SAFE AND HIGHLY EFFECTIVE FOR NEWLY DIAGNOSED FAVORABLE RISK AML.

EHA Library, Brenda Castillo, 4161572

COMPARATIVE EFFECTIVENESS OF OLUTASIDENIB AND IVOSIDENIB IN MIDH1 RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS POST-VENETOCLAX: INSIGHTS FROM 2102-HEM-101 AND A REAL-WORLD EXTERNAL CONTROL

EHA Library, Jorge Cortes, 4161573

EFFICACY AND SAFETY OF MITOXANTRONE HYDROCHLORIDE LIPOSOME COMBINED WITH MODIFIED VA REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: A SINGLE-ARM, MULTI-CENTER STUDY

EHA Library, Jin Yin, 4161574

GEMTUZUMAB OZOGAMICIN AS FIRST LINE TREATMENT OF ACUTE MYELOID LEUKAEMIA (AML) WITH FAVOURABLE PROGNOSIS - A REAL LIFE NATIONAL EXPERIENCE FROM GRUPO PORTUGUÊS DE LEUCEMIAS AGUDAS (GLPA)

EHA Library, Sara Vaz da Silva, 4161575

CLINICAL CASE ANALYSIS OF 21 PATIENTS WITH BPDCN AND PDC-AML

EHA Library, Jinjun Yang, 4161576

MEASURABLE RESIDUAL DISEASE ASSESSMENT PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES: A 20-YEAR MONOCENTRIC STUDY.

EHA Library, Alexandre-Raphael Wery, 4161577

„HIT RIGHT AND EARLY” IN AML PATIENTS WITH FLT3-ITD/NPM1/DNMT3A TRIPLE MUTATIONS

EHA Library, Ruixin Li, 4161578

CLINICAL STUDY OF PORCINE ANTI-HUMAN LYMPHOCYTE IMMUNOGLOBULIN COMBINED WITH CYCLOPHOSPHAMIDE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION OF MYELOID MALIGNANCIES

EHA Library, Yali Zhou, 4161579

THE POWER OF ISTH SCORE AND ITS MODIFICATIONS TO PREDICT BLEEDING IN AML PATIENTS PRESENTING WITH DIC

EHA Library, Bedrettin Orhan, 4161581

CLINICAL AND GENETIC FACTORS ASSOCIATED WITH PROGNOSTIC DETERMINATION IN CBF-AML: RESULTS FROM A THAI ACUTE LEUKEMIA WORKING GROUP

EHA Library, Quoc Nguyen, 4161583

LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR THERAPY-RELATED ACUTE MYELOID LEUKEMIA: AN 11-YEAR SINGLE-CENTER COHORT STUDY

EHA Library, Yue Lu, 4161584

IMPACT OF NK RECEPTOR AND LIGAND GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA: A COMPUTATIONAL APPROACH

EHA Library, Camila Garcia, 4161585

MYELOID SARCOMA AND ELN RISK GROUP

EHA Library, Manish Jain, 4161586

TREATMENT PATTERNS IN PATIENTS WITH RELAPSED OR REFRACTORY NPM1 MUTATED ACUTE MYELOID LEUKEMIA IN THE UNITED STATES: A REAL-WORLD DATA ANALYSIS

EHA Library, Huan Huang, 4161587

MITOXANTRONE HYDROCHLORIDE LIPOSOME IN COMBINATION WITH CYTARABINE AND VENETOCLAX (MAV) REGIMEN IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Huafeng Wang, 4161589

G6PD-DEFICIENCY IS ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH AML TREATED WITH VENETOCLAX AND AZACITIDINE

EHA Library, Shira Buchrits, 4161590

PROGNOSTIC IMPLICATIONS OF TP53 MUTATIONS IN ACUTE MYELOID LEUKEMIA: A CRITICAL CONCERN

EHA Library, Linya Wang, 4161591

STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2 EXPRESSION IS ASSOCIATED WITH ADVERSE OUTCOME IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA

EHA Library, Sai Huang, 4161592

EFFICACY OF CPX-351 IN SECONDARY ACUTE MYELOID LEUKEMIA DEFINED ACCORDING TO WHO 2022 CLASSIFICATION.

EHA Library, Fabio Guolo, 4161593

EFFICACY AND SAFETY OF LIPOSOMAL MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA PATIENTS WITHOUT PRIOR EXPOSURE

EHA Library, Kaibo Zhu, 4161594

TREATMENT OF 317 ELDERLY UNFIT PATIENTS WITH AML: RESULTS FROM A SINGLE CENTER

EHA Library, Andrea Kündgen, 4161595

IMPACT OF THE GERIATRIC MULTIDIMENSIONAL ASSESSMENT (GMA) IN ELDERLY AML PATIENTS TREATED WITH HYPOMETHYLATING AGENTS AT THE ANCONA HEMATOLOGY CLINIC*.

EHA Library, Debora Capelli, 4161596

VENETOCLAX PLUS DECITABINE, CYTARABINE, ACLARUBICIN, AND G-CSF IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A MULTICENTER, RETROSPECTIVE STUDY

EHA Library, Yuping Gong, 4161597

IVOSIDENIB COMBINED WITH VENETOCLAX AND AZACITIDINE FOR THE TREATMENT OF NEWLY DIAGNOSED IDH1-MUTANT ACUTE MYELOID LEUKEMIA: A PROSPECTIVE, TWO COHORTS, MULTICENTER STUDY

EHA Library, Haiping Dai, 4161598

PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS (LCH) IN UZBEKISTAN: ANALYSIS OF PROGNOSTIC FACTORS AND OUTCOMES.

EHA Library, Khilola Rustamova, 4161599

STREAM: CREATION AND TECHNICAL IMPLEMENTATION FOR A MULTICENTRE PATIENT REGISTRY FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA

EHA Library, Kalia Orphanou, 4161600

CLINICAL IMPACT OF RESIDUAL GENETIC MUTATIONS AT CR IN ACUTE MYELOID LEUKEMIA

EHA Library, Xin Yan, 4161601

MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF OLUTASIDENIB (OLU) AND IVOSIDENIB (IVO) IN ISOCITRATE DEHYDROGENASE 1 (IDH1)-MUTATED RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Jorge Cortes, 4161602

IMMUNOPHENOTYPIC DIFFERENCES BETWEEN INITIAL PRESENTATION AND INDUCTION THERAPY IN ACUTE MEGAKARYOBLASTIC LEUKEMIA

EHA Library, Hui Wang, 4161603

POST-INDUCTION MRD PREDICTS MOLECULAR RELAPSE IN FAVORABLE-RISK, INTENSIVELY-TREATED NPM1-MUTATED AML

EHA Library, Marco Petrella, 4161604

EFFECT OF RNA SPLICEOSOME MUTATIONS ON OUTCOME AND SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Tao Wu, 4161605

A PHASE 2 STUDY OF CHIDAMIDE IN COMBINATION WITH CAG AND VENETOCLAX-AZACITIDINE IN ELN ADVERSE-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Lei Lv, 4161606

VENETOCLAX-BASED REGIMENS VERSUS INTENSIVE CHEMOTHERAPY AS A BRIDGE TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA

EHA Library, Ekaterina Romaniuk, 4161608

ACUTE MYELOID LEUKEMIA IN HIGH DISEASE BURDEN REGIONS: ANALYSIS OF HEALTHCARE CAPACITY AND COMORBIDITIES IN WESTERN EUROPE, NORTH AMERICA, AND EAST ASIA

EHA Library, Zhangjie Chen, 4161609

FLAG-IDA AND VENETOCLAX IN RELAPSED / REFRACTORY ACUTE MYELOID LEUKEMIA IN AN ASIAN POPULATION

EHA Library, Joshua Tan, 4161610

PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH CPX-351: INSIGHTS INTO MOLECULAR PATTERNS AND TREATMENT RESPONSE

EHA Library, Carola Riva, 4161611

MOLECULAR BACKGROUND OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA RECEIVING INTENSIFIED FLUDARABINE-BASED INDUCTION: EXPLORING THE ROLE OF „SECONDARY TYPE” AND HIGH RISK MUTATIONS

EHA Library, Paola Minetto, 4161612

GENOMIC CHARACTERIZATION OF PEDIATRIC ACUTE MYELOID LEUKEMIA PATIENTS BY NGS IN UKRAINE

EHA Library, Nataliia Levkovych, 4161613

IMPACT OF THE DASATINIB USED BEFORE ALLOHCT ON THE OUTCOME OF CHILDREN WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Lipeng Liu, 4161614

THE EFFICACY AND SURVIVAL ANALYSIS OF FIT-AML PATIENTS TREATED WITH VENETOCLAX COMBINED WITH HYPOMETHYLATING AGENTS (VEN-HMAS)

EHA Library, Xiaojing Yan, 4161615

ANALYSIS OF CLINICAL AND PROGNOSTIC CHARACTERISTICS OF CHILDREN WITH ACUTE MYELOID LEUKEMIA ACCOMPANIED BY MYELODYSPLASTIC-RELATED GENES MUTATIONS

EHA Library, Zihao Xia, 4161616

PROLONGED OVERALL SURVIVAL WITH VENAZA IN AN UNSELECTED REAL-WORLD POPULATION IRRESPECTIVE OF FITNESS FOR INTENSIVE CHEMOTHERAPY

EHA Library, Marta Pereira, 4161617

OUTCOMES OF REAL-WORLD INVESTIGATIONS ON AZACITIDINE PLUS VENETOCLAX IN ACUTE MYELOID LEUKEMIA:ORION-AML STUDY

EHA Library, Thanawat Rattanathammethee, 4161618

PREDICTIVE FACTORS FOR TREATMENT FAILURE IN AML PATIENTS RECEIVING VENETOCLAX COMBINED WITH AZACITIDINE: A REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Zi-Yuan Nie, 4161619

Azacitidine Combined with Intermediate-dose Cytarabine Consolidation in Newly Diagnosed Acute Myeloid Leukemia

EHA Library, Qiuling Wu, 4161620

LOW-DOSE CHEMOTHERAPY FOR INDUCTION REMISSION IN CHINESE CHILDHOOD WITH M2 SUBTYPE OF ACUTE MYELOID LEUKEMIA: A MULTICOHORT, RANDOMIZED PHASE 3 TRIAL

EHA Library, Wenxin Ou, 4161621

IMPACT OF FLT3 MUTATIONS ON DIC PRESENTATION IN DE NOVO AND SECONDARY ACUTE MYELOID LEUKEMIA

EHA Library, Maria Bacanu, 4161622

EFFICACY AND SAFETY OF GILTERITINIB IN R/R FLT3 ACUTE MYELOID LEUKEMIA: A REAL-WORLD STUDY

EHA Library, Ana Maria Hoyos Brea, 4161623

FLOW CYTOMETRIC EVALUATION OF CD110 IS A NOVEL AND SPECIFIC MARKER FOR DIAGNOSIS OF ACUTE MEGAKARYOBLASTIC LEUKEMIA

EHA Library, Hui Wang, 4161624

REAL-WORLD SURVIVAL OF IDH-MUTANT PATIENTS IN CHINA BEFORE IDH-INHIBITOR ERA

EHA Library, Zihan Chen, 4161625

RISK FACTORS AND CLINICAL OUTCOMES OF CANDIDA TROPICALIS VERSUS NON-TROPICALIS CANDIDEMIA IN PATIENTS WITH HEMATOLOGICAL DISORDER

EHA Library, Zhangjie Chen, 4161626

SECONDARY ACUTE ERYTHROID LEUKEMIA: A RARE ENTITY

EHA Library, Angeliki Kotsiafti, 4161627

TRIAL IN PROGRESS: A PHASE 2 STUDY OF AZACITIDINE AND VENETOCLAX FOR ACUTE MYELOID LEUKEMIA WITH MEASURABLE RESIDUAL DISEASE BEFORE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION?

EHA Library, Meira Yisraeli Salman, 4161628

IDENTICAL T(11;12)(P15;Q13) CHROMOSOMAL TRANSLOCATION WITH DISTINCT NUP98::RARG AND NUP98::HOXC13 FUSION GENES IN RARE SUBTYPES OF ACUTE MYELOID LEUKEMIA: THE SIGNIFICANCE OF PRECISE DIAGNOSIS

EHA Library, Tong Wang, 4161629

THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Naima Abdullahi, 4161630

RAPHAEL: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY TO EVALUATE HMPL-306 (RANOSIDENIB) IN PATIENTS (PTS) WITH IDH1- AND/OR IDH2-MUTATED RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Lijuan Hu, 4161631

OUTCOME PREDICTION FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES

EHA Library, Sviatlana Haurylava, 4161632

REAL-WORLD OUTCOMES OF ORAL AZACITIDINE BASED MAINTENANCE THERAPY FOR ACUTE MYELOID LEUKEMIA IN REMISSION: A SINGLE CENTRE EXPERIENCE IN INDIAN POPULATION

EHA Library, Akshay Middinti, 4161633

OPTIMAL TIMING OF MULTICOLOR FLOW CYTOMETRY AND MOLECULAR MEASURABLE RESIDUAL DISEASE ASSESSMENT FOR PREDICTING ACUTE MYELOID LEUKEMIA RELAPSE AND SURVIVAL: A SINGLE-CENTER EXPERIENCE

EHA Library, Alexander Li, 4161634

LOWER-INTENSITY CHEMO-IMMUNOTHERAPY WITH CLADRIBINE, LOW-DOSE CYTARABINE, VENETOCLAX AND BLINATUMOMAB PRODUCES HIGH RESPONSE RATES IN PATIENTS WITH BCR::ABL1-NEGATIVE B/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

EHA Library, Tapan Kadia, 4161635

OUTCOMES OF RECENT NOVEL THERAPEUTIC AGENTS IN TP53-MUTATED ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME IN THE FRONTLINE SETTING

EHA Library, Zaker Schwabkey, 4161636

SELINEXOR-BASED NON-INTENSIVE CHEMOTHERAPY REGIMENS ADJUSTED ACCORDING TO EARLY RESPONSES ACHIEVE HIGH EARLY REMISSION IN NEWLY DIAGNOSED AML OR MDS

EHA Library, Shiyuan Zhang, 4161637

ACUTE MYELOID LEUKEMIA WITH T(11;20)/NUP98::TOP1

EHA Library, Shaobin Yang, 4161638

VENETOCLAX-BASED REGIMENS AS FIRST-LINE TREATMENT IN ADULT PATIENTS WITH NEWLY DIAGNOSED POOR-RISK CYTOGENETIC RISK AML. SINGLE CENTER EXPERIENCE

EHA Library, Nikita Pastukhov, 4161639

A PHASE 1 OPEN-LABEL TRIAL OF LAVA-1266, A CD123-TARGETING BISPECIFIC Vγ9VΔ2-T CELL ENGAGER, IN PATIENTS WITH CD123 POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) AND INTERMEDIATE TO EXTREMELY HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Shaun Fleming, 4161640

DIAGNOSIS AND TREATMENT OF ACUTE ERYTHROID LEUKAEMIA

EHA Library, Zois Mellios, 4161641

VENETOCLAX COMBINED WITH IDAUNORUBICIN AND CYTARABINE(2+3) AS INDUCTION TREATMENT IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, xuexing Chen, 4161642

CLINICAL IMPACT OF DNMT3A, TET2 AND ASXL1 MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anastasiia Kashlakova, 4161643

FINITE-DURATION VENETOCLAX-AZACITIDINE PLUS DECITABINE PRIMING WITH CYTARABINE FOLLOWED BY UMBILICAL CORD BLOOD INFUSION IMPROVES SURVIVAL IN UNFIT ELDERLY PATIENTS WITH UNTREATED AML: A RETROSPECTIVE ANALYSIS

EHA Library, Li Ye, 4161644

NK-CELLS INFUSIONS TO PREVENT RELAPSE AND REDUCE TOXICITY IN STANDART RISK AML

EHA Library, Maryia Navumovich, 4161645

EFFECT OF CYTOREDUCTIVE CHEMOTHERAPY ON THE INCIDENCE OF DIFFERENTIATION SYNDROME IN PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Zhiling Yan, 4161646

REGISTRATIONAL PHASE 3 STUDY OF ZIFTOMENIB IN COMBINATION WITH NON-INTENSIVE OR INTENSIVE CHEMOTHERAPY FOR NEWLY DIAGNOSED NPM1-M AND/OR KMT2A-R ACUTE MYELOID LEUKEMIA (AML): THE KOMET-017 TRIAL

EHA Library, Amer M. Zeidan, 4161647

AGE-RELATED DISPARITIES IN ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER COMPARATIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND OUTCOMES IN ADOLESCENTS/YOUNG ADULTS VERSUS OLDER ADULTS

EHA Library, Omar Shahin, 4161648

THE ROLE OF INTERIM BONE MARROW ASSESSMENTS IN ACUTE MYELOID LEUKEMIA - A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Yuanli Lei, 4161649

A PHASE 1 STUDY OF REVUMENIB + INTENSIVE CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA HARBORING GENETIC ALTERATIONS IN KMT2A, NPM1, OR NUP98 (SNDX-5613-0708)

EHA Library, Ibrahim Aldoss, 4161650